MAPT and Alzheimer disease: Interestingly, this result is consistent with the findings from human AD study (Ahmad et al., 2020), which reported that LPAs (C16:0, C16:1) were significantly linked to AD biomarkers in CSF (Aβ-42, p-tau, and total tau), suggesting that LPAs play a role in AD.